COVID-19 in haematology

Proposals should address COVID-19 infection in malignant and benign haematologic disorders or haematological and immunological manifestations in COVID-19 infection.

Amount
€120.000
Eligibility (if available)

Home or host institute must be in Europe

Foreign participation? (where known)
Yes
Country
Date application deadline